Alpha-Ketoglutarate Influences the Self-Renewal and Differentiation of Pluripotent Stem Cells by TeSlaa, Tara
UCLA
UCLA Electronic Theses and Dissertations
Title
Alpha-Ketoglutarate Influences the Self-Renewal and Differentiation of Pluripotent Stem 
Cells
Permalink
https://escholarship.org/uc/item/6zx342cd
Author
TeSlaa, Tara
Publication Date
2017
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 UNIVERSITY OF CALIFORNIA 
Los Angeles 
 
 
 
Alpha-Ketoglutarate Influences the  
Self-Renewal and Differentiation of Pluripotent Stem Cells 
 
 
 
A dissertation submitted in partial satisfaction of the 
Requirements for the degree Doctor of Philosophy 
In Molecular Biology 
 
by 
 
Tara Ann TeSlaa 
 
 
 
 
 
 
 
 
2017 
  
 
 ii 
ABSTRACT OF THE DISSERTATION 
 
Alpha-Ketoglutarate Influences the  
Self-Renewal and Differentiation of Pluripotent Stem Cells 
 
by 
 
Tara Ann TeSlaa 
Doctor of Philosophy in Molecular Biology 
University of California, Los Angeles, 2017 
Professor Michael Alan Teitell, Chair 
 
Human pluripotent stem cells (hPSCs) hold great potential for regenerative medicine due to their ability 
to self-renew indefinitely in in vitro culture and to differentiate into all three germ layers. However, the 
use of hPSCs in the clinic has been limited by the lack of differentiation protocols that produce fully 
mature and functional cell types. Development of more efficient differentiation strategies therefore will be 
key to fully realizing the therapeutic potential of hPSCs. Differentiation occurs through epigenetic 
changes that turn off genes important for self-renewal and activate genes required for cellular maturation 
and specialization. In addition, cellular metabolism shifts to address varying energetic and biosynthetic 
demands. Many metabolites, whose levels are influenced by the overall metabolic network, act as 
cofactors for enzymes that control the epigenetic state of the cell. α-Ketoglutarate (αKG), a TCA cycle 
metabolite, acts as a cofactor for αKG-dependent dioxygenases which included the JmjC-domain containing 
family of histone demethylases (JHDMs) and the Ten-eleven translocation (TET) methylcytosine oxidases. 
Succinate, another TCA cycle metabolite, acts as an inhibitor of the same αKG-dependent dioxygenases. 
Therefore, changes in the αKG-to-succinate ratio caused by changes in cellular metabolism impact the activity 
of αKG-dependent dioxygenases and therefore gene expression. Both JHDMs and TETs have known roles in 
 iii 
pluripotent stem cell self-renewal and differentiation. Recently, αKG has been reported to support self-renewal 
in mouse embryonic stem cells (mESCs). However, mESCs differ from traditionally maintained hPSCs in 
numerous ways including their stages of pluripotency. Both mESCs and human embryonic stem cells are 
derived from the inner cell mass, but mESCs are traditionally maintained in an earlier developmental state, 
called the naïve state, corresponding to the preimplantation embryo. hESCs are traditionally maintained in a 
more differentiated state, called the primed pluripotent state, corresponding to the post-implantation epiblast. 
Therefore, because the role of αKG in hPSCs has not previously been investigated, we examined the role of 
αKG in primed hPSC differentiation. We discovered that αKG can accelerate the differentiation of primed 
hPSCs likely through its action on αKG-dependent dioxygenases. Because αKG promotes self-renewal in 
mESCs, we investigated whether αKG promotes differentiation of primed mouse pluripotent stem cells derived 
from the post-implantation embryo called Epiblast stem cells (EpiSCs). αKG also promoted differentiation in 
mouse EpiSCs which suggests that the role of αKG is dependent on the stage of pluripotency and is not species 
dependent. To further confirm the role of αKG in hPSC differentiation, we decreased the αKG-to-succinate 
ratio by inhibition of αKG producing enzymes or succinate consuming enzymes during hPSC differentiation. 
Both manipulations led to a delay of hPSC differentiation. Finally, manipulation of the αKG-to-succinate ratio 
led to changes in DNA hydroxymethylation and histone methylation levels suggesting an epigenetic 
mechanism. Taken together, my data suggests that αKG plays a context specific, differentiation promoting role 
in primed pluripotent stem cells. 
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Chapter 1: 
 
Introduction 
 
 
2 
 
Clinical Potential and Current Roadblocks of Human Pluripotent Stem Cells (hPSCs) 
 
Human pluripotent stem cells (hPSCs) encompass both human embryonic stem cells (hESCs) which are 
derived from the inner cell mass (ICM) of the human blastocyst (Thomson et al., 1998) and human 
induced pluripotent stem cells (hIPSCs) which are reprogrammed from somatic cells to a pluripotent state 
through forced expression of a combination of transcription factors required for pluripotency (Boyer et 
al., 2005; Takahashi et al., 2007). hPSCs self-renew in culture and can differentiate into all three germ 
layers making them useful for regenerative medicine applications in which cell replacement is a viable 
therapy (Gearhart, 1998). However, some current differentiation protocols produce cell types that are 
immature and as a result exhibit only limited functionality (Später et al., 2014). Extended time in culture 
can induce maturation of hPSC derived cells (Lundy et al., 2013). However, time in culture increases the 
cost and labor required for production of hPSC-derived cells decreasing the feasibility of their use 
clinically. Furthermore, protracted time in culture of hPSCs can lead to chromosomal aberrations (Baker 
et al., 2007; Draper et al., 2004; Laurent et al., 2011; Mayshar et al., 2010).   
 
Variability exists between individual hESC and hIPSC lines resulting in a disparity in the ability of 
individual lines to differentiate into each of the three germ layers.  This problem, termed lineage bias, 
complicates efforts to improve differentiation protocols (Burrows et al., 2016; Cahan and Daley, 2013; 
Nazareth et al., 2013; Newman and Cooper, 2010; Osafune et al., 2008). Genetic diversity, epigenetic 
alterations, or genetic alterations contribute to lineage bias (Burrows et al., 2016; Cahan and Daley, 2013; 
Kim et al., 2011). In the case of hIPSCs, cell type of origin can also lead to an epigenetic memory that 
influences lineage bias (Kim et al., 2011). Strategies to overcome lineage bias are also important in 
enabling the use of hPSCs clinically (Wright et al., 2014).  In addition, considerable heterogeneity exists 
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within single hPSC lines. Both lineage primed and self-renewing subpopulations exist within single hPSC 
lines (Hough et al., 2014).  
 
Developmental Stages of Pluripotency in Mouse and Human 
 
Pluripotent cells can be derived from two stages of development: the inner cell mass (ICM) of the 
preimplantation blastocyst or from the epiblast after implantation into the uterus (Tesar et al., 2007). In 
mice, cells derived from the developmentally immature ICM of the embryo, referred to as mouse 
embryonic stem cells (mESCs), are in maintained in this undifferentiated state that has been termed the 
naïve pluripotent state. Mouse cells derived from the slightly more mature postimplantation epiblast are 
termed epiblast stem cells (EpiSCs) and are maintained in this more differentiated state termed the primed 
pluripotent state (Brons et al., 2007; Martin, 1981; Tesar et al., 2007). Self-renewal of naïve mESCs is 
promoted in vitro by the presence of leukemia inhibitory factor (LIF). Naïve mESCs can also efficiently 
contribute to chimera production (Smith et al., 1988; Williams et al., 1988). Mouse EpiSCs, in contrast, 
self-renew in response to basic fibroblast growth factor (bFGF) and transforming growth factor beta 
(TGFβ), and cannot contribute to chimera formation when transplanted into the early preimplantation 
gastrula (Greber et al., 2010; Mascetti and Pedersen, 2016).  
 
Traditionally cultured hPSCs, despite being derived from the ICM, share several characteristics with 
EpiSCs including similar morphologies, metabolism and epigenetics and therefore are considered primed 
pluripotent stem cells (PSCs) (Nichols and Smith, 2009). While primed PSCs cannot produce a chimeric 
mouse when injected into the early blastocyst, when transplanted into the post-implantation gastrula 
primed hPSCs are able to colonize the gastrula and depending on the site of injection can differentiation 
into each germ layer in a predictable manner (Mascetti and Pedersen, 2016). This stage-matched 
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incorporation of PSCs into the developing embryo emphasizes the differences in developmental stages in 
these cell states and culture conditions despite shared their potential to differentiate into all germ layers.  
 
Naïve pluripotent stem cells have some practical advantages over the primed pluripotent state. Naïve 
PSCs have low levels of both DNA methylation and trimethylation of histone H3 lysine 27 when 
compared to primed PSCs (Bernstein et al., 2006; Hayashi et al., 2008; Leitch et al., 2013; Marks et al., 
2012; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007). These epigenetic differences result in 
naïve mESC cell lines that are relatively homogeneous and do not exhibit lineage bias (Marks et al., 
2012). Furthermore, primed PSCs generally undergo apoptosis in response to dissociation into single cells 
(Chen et al., 2010; Ohgushi et al., 2010; Watanabe et al., 2007). In contrast to primed pluripotent stem 
cells, mESCs can easily survive dissociation into single cells for clonal expansion making them easier to 
genetically modify. Therefore, much research has been aimed at identifying conditions in which hPSCs 
can be either reprogrammed from a primed to a naïve state or to derive hPSCs in a naïve pluripotent state. 
This goal has been achieved through a variety of different protocols that utilize many approaches to 
promote naïve pluripotency including the expression of naïve state transcription factors, the addition of 
growth factors, and treatment with small molecule inhibitors (Gafni et al., 2013; Takashima et al., 2014; 
Theunissen et al., 2014; Ware et al., 2014). Gene expression analysis and transcriptional analysis of 
transposable elements determined that naïve hPSCs produced with protocols from Theunissen et al. and 
Takashima et al. best resembled the in vivo human preimplantation ICM (Huang et al., 2014; Theunissen 
et al., 2016). Interestingly, naïve hPSCs exhibit two active X chromosomes despite XIST expression 
which is lost when naïve hPSCs transition into the primed pluripotent state. Further differentiation causes 
XIST re-expression and X chromosome inactivation (XCI) which is maintained during differentiation 
(Sahakyan et al., 2017). This is an improvement from conventional primed hPSCs which do not undergo 
XCI during differentiation (Patel et al., 2017). While these naïve hPSCs exhibit many features of in vivo 
preimplantation pluripotency, incorporation into the mouse blastocyst remains inefficient. It is unclear 
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whether this is due to species differences or imperfect naïve hPSC conditions. In addition, naïve hPSCs 
produced with Theunissen et al. protocol have a scrambled pattern of DNA methylation and lose 
methylation at imprinted loci (Pastor et al., 2016). Furthermore, transition of naïve hPSCs to the primed 
pluripotent state, which is the first step of differentiation, is inefficient and slow. Therefore, much more 
work needs to be done to determine the differences between the naïve and primed pluripotent state and to 
improve PSCs differentiation for clinical application. 
 
Beyond the traditional naïve mESC culture, mouse PSCs can be grown in an even more homogeneous 
undifferentiated pluripotent state termed the ground state. Rather than being maintained on a feeder layer 
with serum and LIF (S/L), ground state mESCs are grown in feeder free conditions in the presence of LIF 
and two inhibitors (2i/L) that support self-renewal, a FGF/Mek/Erk inhibitor PD184352 and a Gsk-3 
inhibitor CHIR99021 (Nichols et al., 2009; Ying et al., 2008). Ground state mESCs exhibit lower levels 
of both DNA and histone methylation when compared to mESCs cultured on feeders (Ficz et al., 2013; 
Habibi et al., 2013).  Furthermore, the gene expression pattern of mESCs cultured in 2i/L confirms a more 
homogeneous population than when mESCs are cultured in S/L (Ficz et al., 2013). 
 
Metabolism in Pluripotency and Differentiation  
 
Previous work from our lab and others has shown that primed hPSCs rely on glycolysis for ATP 
production and shift toward oxidative phosphorylation (OXPHOS) during differentiation (Zhang et al., 
2011; Zhou et al., 2012). Upon differentiation, changes in metabolism can be seen before the decrease in 
the expression of pluripotent markers NANOG and OCT4 (Moussaieff et al., 2015). One regulator of 
primed hPSC metabolism is uncoupling protein 2 (UCP2) which is highly expressed in primed hPSCs and 
decreases during retinoic acid induced differentiation (Zhang et al., 2011). UCP2 is thought to promote 
glycolysis in hPSCs by acting as a transporter of C4 metabolites out of the mitochondria suppressing 
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respiration (Vozza et al., 2014).  Enhancement of glycolysis, by use of hypoxic environments for 
example, promotes pluripotency (Covello et al., 2006; Forristal et al., 2010).  Culture in hypoxic 
conditions enhances reprogramming of fibroblasts to iPSCs by enhancing the shift to glycolytic 
metabolism that occurs during the acquisition of the pluripotent state (Mathieu et al., 2014; Yoshida et al., 
2009). 
 
While OXPHOS is low in primed hPSCs when compared to many differentiated cells, glutamine is 
critical for hPSC survival and self-renewal as it fuels the TCA cycle and is a precursor of glutathione 
(GSH), an important antioxidant in hPSCs (Marsboom et al., 2016; Tohyama et al., 2016; Zhang et al., 
2016). High levels of GSH are maintained and used to combat oxidative stress and DNA damage by high 
expression of glutathione peroxidase 2 (GPX2) in primed hPSCs (Dannenmann et al., 2015). UCP2 
expression in hPSCs also promotes the pentose phosphate pathway, which produces NADPH important 
for reducing glutathione disulfide (GSSG) back to GSH for antioxidant protection (Zhang et al., 2011). 
Low GSH levels induced by the withdrawal of glutamine from hPSC media results in oxidation and 
degradation of pluripotency transcription factor OCT4 leading to differentiation. In this way OCT4 acts as 
a sensor of the redox state of the cell coordinating growth factor signaling and oxidative stress with 
differentiation (Marsboom et al., 2016).  
 
Feeder cells can greatly influence the metabolic state of primed hPSCs. Feeder free conditions promote 
greater dependence on glycolysis when compared to primed hPSCs co-cultured with mouse embryonic 
fibroblasts (MEFs). This feeder free induced shift in metabolism involves increase serine, nucleotide, and 
lipid biosynthesis (Gu et al., 2016; Zhang et al., 2016). Furthermore, feeder free conditions enhance use of 
glucose and glutamine into the TCA cycle while feeder MEF conditioned medium causes more 
respiration, probably due to an increase in fatty acid oxidation. Supplementation of feeder free medium 
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with lipid results in primed hPSC metabolism with increased respiration similar to MEF conditioned 
medium metabolism (Zhang et al., 2016).   
 
Differences in metabolism also exist between the naïve and primed pluripotent states. When compared to 
primed hPSCs, naïve hPSCs have a higher flux of overall glucose metabolism with both glycolysis and 
OXPHOS reported to be higher in the naïve state when compared to the primed pluripotent state. In 
contrast to the human system, mouse naïve PSCs are less glycolytic and more oxidative than their primed 
counterparts, mouse EpiSCs (Zhou et al., 2012). This difference may reflect a developmental difference 
that exists between human and mouse species. In human embryos and naïve hPSCs, high levels of nuclear 
N-Myc may promote increased glucose metabolism and a greater localization of N-Myc is seen in the 
nucleus of the ICM when compared to trophoblast cells. Furthermore an N-Myc inhibitor decreases the 
proliferation of naïve hPSCs while having no effect on primed hPSCs (Gu et al., 2016).  
 
Interconnections Between Metabolism and Epigenetics 
 
Epigenetic alterations are chemical modifications to histones or DNA that result in changes in gene 
expression. Cofactors and co-substrates of many of these reactions are intermediates of metabolic 
pathways, and therefore serve as a link between the metabolic state of the cell and gene expression 
(Kaelin Jr and McKnight, 2013). Naïve mESCs are dependent on threonine catabolism for their survival 
as threonine can fuel one carbon metabolism that is required for nucleotide biosynthesis and s-adenosyl 
methionine (SAM) production, which acts a methyl donor for DNA and histone methylation (Wang et al., 
2009). Inhibition of threonine dehydrogenase (TDH), which converts threonine to serine, in naïve mESCs 
decreases trimethylation of histone H3 lysine 4 (H3K4me3) and promotes differentiation (Shyh-Chang et 
al., 2013). In humans, however, the TDH gene is no longer functional due to three inactivating mutations 
(Wang et al., 2009). In primed hPSCs, methionine acts as the methyl donor for DNA and histone 
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methylation and withdrawal of methionine from the medium potentiates differentiation into all three germ 
layers (Shiraki et al., 2014).  Acetyl-CoA acts as an acetyl group donor for histone acetylation and 
addition of acetate to culture media promotes self-renewal in both naïve mESCs and primed hPSCs 
(Moussaieff et al., 2015).  
 
Several enzymes involved in demethylation of DNA and histones require a TCA cycle metabolite, α-
ketoglutarate (αKG), to act as a cofactor. This group of enzymes, called αKG dependent dioxygenases 
include the JmjC-domain containing family of histone demethylases (JHDMs) and the ten-eleven 
translocation (TET) methylcyotsine dioxygenases (Loenarz and Schofield, 2011). JHDMs hydroxylate 
methylated lysines forming an unstable hydroxymethyl group that is spontaneously lost as formadehyde 
effectively removing the methyl group (Klose and Zhang, 2007). TET enzymes function by hydroxylating 
5-methylcytosine (5mc) in DNA to form 5-hydroxymethylcytosine (5hmc), which can either exist as a 
stable epigenetic mark or be further converted back to an unmethylated cytosine by the same TET 
enzymes (Ito et al., 2010; Tan and Shi, 2012).  When maintained in 2i/L medium in the ground state, 
mESCs use αKG to support self-renewal and maintain the demethylation of DNA and histones (Carey et 
al., 2014).  
 
However, many studies support the role of αKG and αKG-dependent enzymes in promoting 
differentiation. Knockout of the ten eleven translocation (Tet) enzymes, members of the αKG-dependent 
dioxygenase family, impairs differentiation of mESCs through deregulation of developmental promoters 
(Dawlaty et al., 2014). Knockout of only Tet2 leads to delayed gene induction during differentiation (Hon 
et al., 2014). Several JmjC domain containing histone demethylases (JHDMs), also members of the αKG-
dependent dioxygenase family, have been shown to be important in pluripotent stem cell (PSC) 
differentiation. Jumonji and AT-Rich Interaction Domain Containing 2 (JARID2), also known as 
Jumonji, knockout mESCs display delayed expression of differentiation markers due to delayed 
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demethylation of H3K27 (Shen et al., 2009). UTX (ubiquitously transcribed tetratricopeptide repeat X), a 
H3K27 demethylase, is important for the activation of HOX genes in early differentiation, while another 
H3K27 demethylase, JMJD3, is involved in gonad development (Agger et al., 2007; Hong et al., 2007). 
Furthermore, an oncometabolite produced by mutations in isocitrate dehydrogenase (IDH), 2-
hydroxyglutarate (2HG), acts as a competitive inhibitor of αKG-dependent dioxygenases resulting in a 
block in differentiation in tumors harboring these mutations (Losman et al., 2013; Lu et al., 2012; Xu et 
al., 2011). The role of αKG in primed hPSC differentiation has previously been unexplored despite these 
numerous connections. Addition of αKG could serve as a simple way to promote epigenetic remodeling, 
which is required for hPSC differentiation. In addition, because epigenetics play a role in primed hPSC 
line to line variability and lineage bias, αKG-promoted differentiation could be a strategy to address these 
problems and enable efficient differentiation of hPSCs for clinical applications (Burrows et al., 2016; Kim 
et al., 2011; Nazareth et al., 2013). 
 
  
 
 
10 
References 
 
Agger, K., Cloos, P.A.C., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., 
Canaani, E., Salcini, A.E., and Helin, K. (2007). UTX and JMJD3 are histone H3K27 
demethylases involved in HOX gene regulation and development. Nature 449, 731-734. 
Baker, D.E.C., Harrison, N.J., Maltby, E., Smith, K., Moore, H.D., Shaw, P.J., Heath, P.R., 
Holden, H., and Andrews, P.W. (2007). Adaptation to culture of human embryonic stem cells 
and oncogenesis in vivo. Nat Biotech 25, 207-215. 
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, 
A., Wernig, M., Plath, K., et al. (2006). A Bivalent Chromatin Structure Marks Key 
Developmental Genes in Embryonic Stem Cells. Cell 125, 315-326. 
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., 
Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005). Core Transcriptional Regulatory 
Circuitry in Human Embryonic Stem Cells. Cell 122, 947-956. 
Brons, I.G.M., Smithers, L.E., Trotter, M.W.B., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, 
S.M., Howlett, S.K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R.A., et al. (2007). Derivation 
of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195. 
Burrows, C.K., Banovich, N.E., Pavlovic, B.J., Patterson, K., Gallego Romero, I., Pritchard, J.K., 
and Gilad, Y. (2016). Genetic Variation, Not Cell Type of Origin, Underlies the Majority of 
Identifiable Regulatory Differences in iPSCs. PLOS Genetics 12, e1005793. 
Cahan, P., and Daley, G.Q. (2013). Origins and implications of pluripotent stem cell variability 
and heterogeneity. Nat Rev Mol Cell Biol 14, 357-368. 
Carey, B.W., Finley, L.W.S., Cross, J.R., Allis, C.D., and Thompson, C.B. (2014). Intracellular 
[agr]-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature advance online 
publication. 
Chen, G., Hou, Z., Gulbranson, D.R., and Thomson, J.A. (2010). Actin-Myosin Contractility Is 
Responsible for the Reduced Viability of Dissociated Human Embryonic Stem Cells. Cell Stem 
Cell 7, 240-248. 
 
 
11 
Covello, K.L., Kehler, J., Yu, H., Gordan, J.D., Arsham, A.M., Hu, C.J., Labosky, P.A., Simon, 
M.C., and Keith, B. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, 
embryonic development, and tumor growth. Genes Dev 20, 557-570. 
Dannenmann, B., Lehle, S., Hildebrand, Dominic G., Kübler, A., Grondona, P., Schmid, V., 
Holzer, K., Fröschl, M., Essmann, F., Rothfuss, O., et al. (2015). High Glutathione and 
Glutathione Peroxidase-2 Levels Mediate Cell-Type-Specific DNA Damage Protection in 
Human Induced Pluripotent Stem Cells. Stem Cell Reports 4, 886-898. 
Dawlaty, Meelad M., Breiling, A., Le, T., Barrasa, M.I., Raddatz, G., Gao, Q., Powell, 
Benjamin E., Cheng, Albert W., Faull, Kym F., Lyko, F., et al. (2014). Loss of Tet Enzymes 
Compromises Proper Differentiation of Embryonic Stem Cells. Developmental Cell 29, 102-111. 
Draper, J.S., Moore, H.D., Ruban, L.N., Gokhale, P.J., and Andrews, P.W. (2004). Culture and 
Characterization of Human Embryonic Stem Cells. Stem Cells and Development 13, 325-336. 
Ficz, G., Hore, Timothy A., Santos, F., Lee, Heather J., Dean, W., Arand, J., Krueger, F., Oxley, 
D., Paul, Y.-L., Walter, J., et al. (2013). FGF Signaling Inhibition in ESCs Drives Rapid 
Genome-wide Demethylation to the Epigenetic Ground State of Pluripotency. Cell Stem Cell 13, 
351-359. 
Forristal, C.E., Wright, K.L., Hanley, N.A., Oreffo, R.O.C., and Houghton, F.D. (2010). Hypoxia 
inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured 
at reduced oxygen tensions. Reproduction (Cambridge, England) 139, 85-97. 
Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben-Yosef, D., Kalma, 
Y., Viukov, S., Maza, I., and Zviran, A. (2013). Derivation of novel human ground state naive 
pluripotent stem cells. Nature 504, 282-286. 
Gearhart, J. (1998). New Potential for Human Embryonic Stem Cells. Science 282, 1061-1062. 
Greber, B., Wu, G., Bernemann, C., Joo, J.Y., Han, D.W., Ko, K., Tapia, N., Sabour, D., 
Sterneckert, J., Tesar, P., et al. (2010). Conserved and Divergent Roles of FGF Signaling in 
Mouse Epiblast Stem Cells and Human Embryonic Stem Cells. Cell Stem Cell 6, 215-226. 
Gu, W., Gaeta, X., Sahakyan, A., Chan, Alanna B., Hong, Candice S., Kim, R., Braas, D., Plath, 
K., Lowry, William E., and Christofk, Heather R. (2016). Glycolytic Metabolism Plays a 
Functional Role in Regulating Human Pluripotent Stem Cell State. Cell Stem Cell 19, 476-490. 
 
 
12 
Habibi, E., Brinkman, Arie B., Arand, J., Kroeze, Leonie I., Kerstens, Hindrik H.D., Matarese, 
F., Lepikhov, K., Gut, M., Brun-Heath, I., Hubner, Nina C., et al. (2013). Whole-Genome 
Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic 
Stem Cells. Cell Stem Cell 13, 360-369. 
Hayashi, K., Lopes, S.M.C.d.S., Tang, F., and Surani, M.A. (2008). Dynamic Equilibrium and 
Heterogeneity of Mouse Pluripotent Stem Cells with Distinct Functional and Epigenetic States. 
Cell Stem Cell 3, 391-401. 
Hon, Gary C., Song, C.-X., Du, T., Jin, F., Selvaraj, S., Lee, Ah Y., Yen, C.-a., Ye, Z., Mao, S.-
Q., Wang, B.-A., et al. (2014). 5mC Oxidation by Tet2 Modulates Enhancer Activity and Timing 
of Transcriptome Reprogramming during Differentiation. Molecular Cell 56, 286-297. 
Hong, S., Cho, Y.-W., Yu, L.-R., Yu, H., Veenstra, T.D., and Ge, K. (2007). Identification of 
JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proceedings of 
the National Academy of Sciences 104, 18439-18444. 
Hough, Shelley R., Thornton, M., Mason, E., Mar, Jessica C., Wells, Christine A., and Pera, 
Martin F. (2014). Single-Cell Gene Expression Profiles Define Self-Renewing, Pluripotent, and 
Lineage Primed States of Human Pluripotent Stem Cells. Stem Cell Reports 2, 881-895. 
Huang, K., Maruyama, T., and Fan, G. (2014). The Naive State of Human Pluripotent Stem 
Cells: A Synthesis of Stem Cell and Preimplantation Embryo Transcriptome Analyses. Cell Stem 
Cell 15, 410-415. 
Ito, S., D/'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., and Zhang, Y. (2010). Role of 
Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. 
Nature 466, 1129-1133. 
Kaelin Jr, William G., and McKnight, Steven L. (2013). Influence of Metabolism on Epigenetics 
and Disease. Cell 153, 56-69. 
Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Hongguang, H., Loh, Y.-H., 
Aryee, M.J., Lensch, M.W., et al. (2011). Donor cell type can influence the epigenome and 
differentiation potential of human induced pluripotent stem cells. Nat Biotech 29, 1117-1119. 
Klose, R.J., and Zhang, Y. (2007). Regulation of histone methylation by demethylimination and 
demethylation. Nat Rev Mol Cell Biol 8, 307-318. 
 
 
13 
Laurent, L.C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J.V., 
Lee, S., Barrero, M.J., et al. (2011). Dynamic Changes in the Copy Number of Pluripotency and 
Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in 
Culture. Cell Stem Cell 8, 106-118. 
Leitch, H.G., McEwen, K.R., Turp, A., Encheva, V., Carroll, T., Grabole, N., Mansfield, W., 
Nashun, B., Knezovich, J.G., Smith, A., et al. (2013). Naive pluripotency is associated with 
global DNA hypomethylation. Nat Struct Mol Biol 20, 311-316. 
Loenarz, C., and Schofield, C.J. (2011). Physiological and biochemical aspects of hydroxylations 
and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends in Biochemical 
Sciences 36, 7-18. 
Losman, J.-A., Looper, R.E., Koivunen, P., Lee, S., Schneider, R.K., McMahon, C., Cowley, 
G.S., Root, D.E., Ebert, B.L., and Kaelin, W.G. (2013). (<em>R</em>)-2-Hydroxyglutarate Is 
Sufficient to Promote Leukemogenesis and Its Effects Are Reversible. Science 339, 1621-1625. 
Lu, C., Ward, P.S., Kapoor, G.S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C.R., 
Khanin, R., Figueroa, M.E., Melnick, A., et al. (2012). IDH mutation impairs histone 
demethylation and results in a block to cell differentiation. Nature 483, 474-478. 
Lundy, S.D., Zhu, W.-Z., Regnier, M., and Laflamme, M.A. (2013). Structural and functional 
maturation of cardiomyocytes derived from human pluripotent stem cells. Stem cells and 
development 22, 1991-2002. 
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Kranz, 
A., Francis Stewart, A., Smith, A., et al. (2012). The Transcriptional and Epigenomic 
Foundations of Ground State Pluripotency. Cell 149, 590-604. 
Marsboom, G., Zhang, G.-F., Pohl-Avila, N., Zhang, Y., Yuan, Y., Kang, H., Hao, B., 
Brunengraber, H., Malik, Asrar B., and Rehman, J. (2016). Glutamine Metabolism Regulates the 
Pluripotency Transcription Factor OCT4. Cell Reports 16, 323-332. 
Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in 
medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of 
Sciences 78, 7634-7638. 
Mascetti, Victoria L., and Pedersen, Roger A. (2016). Human-Mouse Chimerism Validates 
Human Stem Cell Pluripotency. Cell Stem Cell 18, 67-72. 
 
 
14 
Mathieu, J., Zhou, W., Xing, Y., Sperber, H., Ferreccio, A., Agoston, Z., Kuppusamy, 
Kavitha T., Moon, Randall T., and Ruohola-Baker, H. (2014). Hypoxia-Inducible Factors Have 
Distinct and Stage-Specific Roles during Reprogramming of Human Cells to Pluripotency. Cell 
Stem Cell 14, 592-605. 
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A.T., Plath, K., 
Lowry, W.E., and Benvenisty, N. (2010). Identification and Classification of Chromosomal 
Aberrations in Human Induced Pluripotent Stem Cells. Cell Stem Cell 7, 521-531. 
Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., 
Brockman, W., Kim, T.-K., Koche, R.P., et al. (2007). Genome-wide maps of chromatin state in 
pluripotent and lineage-committed cells. Nature 448, 553-560. 
Moussaieff, A., Rouleau, M., Kitsberg, D., Cohen, M., Levy, G., Barasch, D., Nemirovski, A., 
Shen-Orr, S., Laevsky, I., Amit, M., et al. (2015). Glycolysis-Mediated Changes in Acetyl-CoA 
and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells. Cell 
Metabolism 21, 392-402. 
Nazareth, E.J.P., Ostblom, J.E.E., Lucker, P.B., Shukla, S., Alvarez, M.M., Oh, S.K.W., Yin, T., 
and Zandstra, P.W. (2013). High-throughput fingerprinting of human pluripotent stem cell fate 
responses and lineage bias. Nat Meth 10, 1225-1231. 
Newman, A.M., and Cooper, J.B. (2010). Lab-Specific Gene Expression Signatures in 
Pluripotent Stem Cells. Cell Stem Cell 7, 258-262. 
Nichols, J., Silva, J., Roode, M., and Smith, A. (2009). Suppression of Erk signalling promotes 
ground state pluripotency in the mouse embryo. Development 136, 3215-3222. 
Nichols, J., and Smith, A. (2009). Naive and Primed Pluripotent States. Cell Stem Cell 4, 487-
492. 
Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki, T., Nishiyama, A., 
Muguruma, K., Nakano, T., Suga, H., Ueno, M., et al. (2010). Molecular Pathway and Cell State 
Responsible for Dissociation-Induced Apoptosis in Human Pluripotent Stem Cells. Cell Stem 
Cell 7, 225-239. 
Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato, Y., Cowan, C.A., 
Chien, K.R., and Melton, D.A. (2008). Marked differences in differentiation propensity among 
human embryonic stem cell lines. Nat Biotech 26, 313-315. 
 
 
15 
Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., Jonsdottir, G.A., Stewart, R., and 
Thomson, J.A. (2007). Whole-Genome Analysis of Histone H3 Lysine 4 and Lysine 27 
Methylation in Human Embryonic Stem Cells. Cell Stem Cell 1, 299-312. 
Pastor, William A., Chen, D., Liu, W., Kim, R., Sahakyan, A., Lukianchikov, A., Plath, K., 
Jacobsen, Steven E., and Clark, Amander T. (2016). Naive Human Pluripotent Cells Feature a 
Methylation Landscape Devoid of Blastocyst or Germline Memory. Cell Stem Cell 18, 323-329. 
Patel, S., Bonora, G., Sahakyan, A., Kim, R., Chronis, C., Langerman, J., Fitz-Gibbon, S., Rubbi, 
L., Skelton, R.J.P., Ardehali, R., et al. (2017). Human Embryonic Stem Cells Do Not Change 
Their X Inactivation Status during Differentiation. Cell Reports 18, 54-67. 
Sahakyan, A., Kim, R., Chronis, C., Sabri, S., Bonora, G., Theunissen, T.W., Kuoy, E., 
Langerman, J., Clark, A.T., Jaenisch, R., et al. (2017). Human Naive Pluripotent Stem Cells 
Model X Chromosome Dampening and X Inactivation. Cell Stem Cell 20, 87-101. 
Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Yuan, G.-C., Lee, Y., 
and Orkin, S.H. (2009). Jumonji Modulates Polycomb Activity and Self-Renewal versus 
Differentiation of Stem Cells. Cell 139, 1303-1314. 
Shiraki, N., Shiraki, Y., Tsuyama, T., Obata, F., Miura, M., Nagae, G., Aburatani, H., Kume, K., 
Endo, F., and Kume, S. (2014). Methionine Metabolism Regulates Maintenance and 
Differentiation of Human Pluripotent Stem Cells. Cell Metabolism 19, 780-794. 
Shyh-Chang, N., Locasale, J.W., Lyssiotis, C.A., Zheng, Y., Teo, R.Y., Ratanasirintrawoot, S., 
Zhang, J., Onder, T., Unternaehrer, J.J., Zhu, H., et al. (2013). Influence of Threonine 
Metabolism on S-Adenosylmethionine and Histone Methylation. Science 339, 222-226. 
Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M., and Rogers, D. 
(1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. 
Nature 336, 688-690. 
Später, D., Hansson, E.M., Zangi, L., and Chien, K.R. (2014). How to make a cardiomyocyte. 
Development 141, 4418-4431. 
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. 
(2007). Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. 
Cell 131, 861-872. 
 
 
16 
Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Santos, F., 
Clarke, J., Mansfield, W., et al. (2014). Resetting Transcription Factor Control Circuitry toward 
Ground-State Pluripotency in Human. Cell 158, 1254-1269. 
Tan, L., and Shi, Y.G. (2012). Tet family proteins and 5-hydroxymethylcytosine in development 
and disease. Development 139, 1895-1902. 
Tesar, P.J., Chenoweth, J.G., Brook, F.A., Davies, T.J., Evans, E.P., Mack, D.L., Gardner, R.L., 
and McKay, R.D.G. (2007). New cell lines from mouse epiblast share defining features with 
human embryonic stem cells. Nature 448, 196-199. 
Theunissen, Thorold W., Friedli, M., He, Y., Planet, E., O’Neil, Ryan C., Markoulaki, S., Pontis, 
J., Wang, H., Iouranova, A., Imbeault, M., et al. (2016). Molecular Criteria for Defining the 
Naive Human Pluripotent State. Cell Stem Cell 19, 502-515. 
Theunissen, Thorold W., Powell, Benjamin E., Wang, H., Mitalipova, M., Faddah, Dina A., 
Reddy, J., Fan, Zi P., Maetzel, D., Ganz, K., Shi, L., et al. (2014). Systematic Identification of 
Culture Conditions for Induction and Maintenance of Naive Human Pluripotency. Cell Stem Cell 
15, 471-487. 
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., 
and Jones, J.M. (1998). Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 
282, 1145-1147. 
Tohyama, S., Fujita, J., Hishiki, T., Matsuura, T., Hattori, F., Ohno, R., Kanazawa, H., Seki, T., 
Nakajima, K., Kishino, Y., et al. (2016). Glutamine Oxidation Is Indispensable for Survival of 
Human Pluripotent Stem Cells. Cell Metabolism 23, 663-674. 
Vozza, A., Parisi, G., De Leonardis, F., Lasorsa, F.M., Castegna, A., Amorese, D., Marmo, R., 
Calcagnile, V.M., Palmieri, L., Ricquier, D., et al. (2014). UCP2 transports C4 metabolites out of 
mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci U S A 111, 960-
965. 
Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O., and McKnight, S.L. (2009). 
Dependence of mouse embryonic stem cells on threonine catabolism. Science 325, 435-439. 
Ware, C.B., Nelson, A.M., Mecham, B., Hesson, J., Zhou, W., Jonlin, E.C., Jimenez-Caliani, 
A.J., Deng, X., Cavanaugh, C., and Cook, S. (2014). Derivation of naïve human embryonic stem 
cells. Proceedings of the National Academy of Sciences 111, 4484-4489. 
 
 
17 
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, 
J.B., Nishikawa, S., Nishikawa, S.-i., Muguruma, K., et al. (2007). A ROCK inhibitor permits 
survival of dissociated human embryonic stem cells. Nat Biotech 25, 681-686. 
Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A., Stewart, C.L., Gearing, D.P., Wagner, 
E.F., Metcalf, D., Nicola, N.A., and Gough, N.M. (1988). Myeloid leukaemia inhibitory factor 
maintains the developmental potential of embryonic stem cells. Nature 336, 684-687. 
Wright, L.S., Phillips, M.J., Pinilla, I., Hei, D., and Gamm, D.M. (2014). Induced pluripotent 
stem cells as custom therapeutics for retinal repair: Progress and rationale. Experimental Eye 
Research 123, 161-172. 
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, 
M.-T., et al. (2011). Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-
Ketoglutarate-Dependent Dioxygenases. Cancer Cell 19, 17-30. 
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and 
Smith, A. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523. 
Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., and Yamanaka, S. (2009). Hypoxia enhances 
the generation of induced pluripotent stem cells. Cell stem cell 5, 237-241. 
Zhang, H., Badur, Mehmet G., Divakaruni, Ajit S., Parker, Seth J., Jäger, C., Hiller, K., Murphy, 
Anne N., and Metallo, Christian M. (2016). Distinct Metabolic States Can Support Self-Renewal 
and Lipogenesis in Human Pluripotent Stem Cells under Different Culture Conditions. Cell 
Reports 16, 1536-1547. 
Zhang, J., Khvorostov, I., Hong, J.S., Oktay, Y., Vergnes, L., Nuebel, E., Wahjudi, P.N., 
Setoguchi, K., Wang, G., Do, A., et al. (2011). UCP2 regulates energy metabolism and 
differentiation potential of human pluripotent stem cells. The EMBO journal 30, 4860-4873. 
Zhao, X.D., Han, X., Chew, J.L., Liu, J., Chiu, K.P., Choo, A., Orlov, Y.L., Sung, W.-K., 
Shahab, A., Kuznetsov, V.A., et al. (2007). Whole-Genome Mapping of Histone H3 Lys4 and 27 
Trimethylations Reveals Distinct Genomic Compartments in Human Embryonic Stem Cells. Cell 
Stem Cell 1, 286-298. 
Zhou, W., Choi, M., Margineantu, D., Margaretha, L., Hesson, J., Cavanaugh, C., Blau, C.A., 
Horwitz, M.S., Hockenbery, D., Ware, C., et al. (2012). HIF1α induced switch from bivalent to 
 
 
18 
exclusively glycolytic metabolism during ESC‐to‐EpiSC/hESC transition. The EMBO journal 
31, 2103-2116. 
 
 19 
Chapter 2: 
 
Pluripotent stem cell energy metabolism: an update 
 
 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 
 36 
Chapter 3: 
 
α-Ketoglutarate accelerates the initial differentiation 
 of primed human pluripotent 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 69 
 
 70 
Chapter 4: 
 
Low oxygen tension inhibits human pluripotent stem cell 
differentiation 
 
 71 
INTRODUCTION 
Hypoxic conditions can promote self-renewal of human pluripotent stem cells (hPSCs) and 
reprogramming of somatic cells to pluripotency (Ezashi et al., 2005; Forristal et al., 2013; 
Forristal et al., 2010; Forsyth et al., 2006; Mathieu et al., 2013; Mathieu et al., 2014; Prasad et 
al., 2009; Yoshida et al., 2009; Zhou et al., 2012). One mechanism by which low oxygen tension 
is thought to promote pluripotency is through hypoxia inducible factor 1α (HIF1α) and hypoxia 
inducible factor 2α (HIF2α).  HIF2α has been shown to promote expression of stem cell 
transcription factor Oct4 (Covello et al., 2006), while both HIF1α and HIF2α can promote a shift 
to glycolysis during reprogramming (Mathieu et al., 2014; Prigione et al., 2014). The stability of 
HIF enzymes in response to oxygen tension is regulated by prolyl hydroxylase enzymes that 
depend on O2, Fe2+, ascorbate and α-ketoglutarate (αKG) for their activity (Bruick and 
McKnight, 2001; Jaakkola et al., 2001; Yu et al., 2001).  
 
Oxygen tension can also play a role in promoting the differentiation process. Low oxygen 
environments favor ectoderm differentiation in hPSCs and promote gliogenesis in human neural 
progenitor cells (Xie et al., 2014).  Furthermore, hypoxia can improve human embryonic stem 
cell (hESC) differentiation into retinal progenitors and endothelium (Bae et al., 2011; Prado‐
Lopez et al., 2010).  In the mouse system, physiologic hypoxia has been shown to be required for 
proliferation and survival of hematopoietic precursors during development (Adelman et al., 
1999).  In summary, low oxygen environments can both enhance self-renewal of hPSCs and 
promote their differentiation in some contexts. 
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TCA cycle metabolite αKG can promote differentiation of hPCSs probably through the 
activation of αKG-dependent dioxygenases including Jumonji domain containing histone 
demethylases (JHDMs) and ten-eleven translocation (TET) methylcytosine oxidases (TeSlaa et 
al., 2016). Like HIF prolyl hydroxylases, these enzymes are also dependent on O2, Fe2+, 
ascorbate and α-ketoglutarate (αKG), and can be inhibited by metabolites with chemical 
structures similar to αKG, such as succinate and L-2-hydroxyglutarate (L-2HG). L-2HG has 
recently been shown to be produced in low oxygen environments through promiscuous activity 
of lactate dehydrogenase A (LDHA) and malate dehydrogenase (MDH) (Intlekofer et al., 2015; 
Intlekofer et al., 2017; Oldham et al., 2015; Xu et al., 2011). Therefore, hypoxia may affect self-
renewal and differentiation through three mechanisms: 1) direction inhibition of αKG-dependent 
dioxygenases, including JHDMs, TET, and PHDs due to low oxygen availability, 2) inhibition of 
αKG-dependent dioxygenases by L-2HG or 3) stabilization of HIF leading to gene expression 
changes. 
 
In this chapter, the role of hypoxia in hPSC differentiation is investigated. We show that very 
low oxygen environments cause HIF-independent inhibition of hPSC differentiation and 
investigate whether this is due to 2HG accumulation or direct inhibition of αKG-dependent 
dioxygenases.  
 
MATERIALS AND METHODS 
hPSC Culture 
hPSCs (H9, UCLA1, HIPS2) (Diaz Perez et al., 2012; Lowry et al., 2008; Thomson et al., 1998) 
were cultured on CF-1 irradiated MEF (Global Stem) feeder layer in DMEM/F12 supplemented 
 73 
with 20% KnockOut serum replacement (ThermoFisher), 1% Glutamax, 1% Pen/Strep, 1% non-
essential amino acids, 0.1mM 2-mercaptoethanol, and 10ng/ml bFGF (R&D Systems). Cells 
were passaged with collagenase IV (Life Technologies) and converted to feeder-free conditions 
prior to differentiation or exposure to hypoxia. Feeder-free hPSCs were grown on growth factor 
reduced Matrigel (Corning) in mTeSR1 (Stem Cell Technologies) and passaged using gentle cell 
dissociation reagent (Stem Cell Technologies). Oxygen level was controlled using a HeraCell 
150i Tri-Gas Incubator (ThermoFisher Scientific). 
 
Lentivirus-mediated shRNA Knockdown 
pLKO.1 vectors were obtained from Sigma-Aldrich containing either shRNA targeting ARNT 
RNA transcripts (TRCN0000003819 (shARNT #19) and TRCN0000003816 (shARNT#16)) or a 
scrambled control sequence.  Lentivirus production was achieved by co-transfection of each 
vector with pCMV-dR8.9 and pCMV-VSVG into HEK 293FT cells using TransIT-293 
Transfection Reagent (Mirus Bio). Transfected HEK 293FT cells were treated with 5mM sodium 
butyrate (Sigma) for 8 hours on the day following transfection. Culture medium was collected 48 
and 72 hours post-transfection and lentivirus was concentrated from culture media using Lenti-X 
Concentrator (Clonetech). Lentivirus was aliquoted and stored at -80°C until use on hPSCs. 
Feeder-free hPSCs were transduced by addition of 25μl of 1 x 107 TU/ml of viral particles 
overnight. Transduction was repeated 4 times before initiation of selection by treatment with 
1μg/ml puromycin.  Initially puromycin was maintained in the medium for 3 passages and 
thereafter added to the medium for two days prior to passaging of the cells.  
 
Chemicals and Antibodies 
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Dimethyl 2-oxoglutarate (dm-αKG) was purchased from Sigma.  Dm-αKG was diluted in 
DMEM/F12 to 800mM and the pH was adjusted to 7.2 before addition to cell culture and final 
concentration. Antibodies used in this study are listed in the table below. 
Primary Antibodies 
Antigen Application Conjugation Source (catalog 
number) 
Dilution 
PAX6 Flow cytometry PerCP-Cy5.5 BD Bioscience 
(562388) 
5μl/sample 
 
ARNT/HIF1beta Immunoblot n/a Novus Biologicals 
(NB100-124) 
1:500 
HDAC1 Immunoblot n/a Santa Cruz Biotech 1:1000 
  
 
Neuroectoderm Differentiation 
For differentiation, hPSCs were dissociated into single cells by exposure to gentle cell 
dissociation reagent (Stem Cell Technologies) for 15 minutes. Cells plated in mTeSR (Stem Cell 
Technologies) with 10μM Y-27632 (BioPioneer) at a concentration of 4 x 105 or 8 x 105 cells per 
well of a 12 or 24 well plate, respectively.  One day after plating (day 0), medium was changed 
to RPMI (ThermoFisher) supplemented with 2% B27 (ThermoFisher), 1% N-2 supplement 
(ThermoFisher), 10μM SB431542 (Stemgent), 0.2μM Dorsomorphin (Stemgent), 1% glutamax, 
and 1% non-essential amino acids (ThermoFisher). In experiments with low oxygen tensions, 
cells were transferred to hypoxic incubator after medium change on day 0 and maintained in the 
hypoxic incubator throughout differentiation. 
 
Flow Cytometry Analysis 
To collect cells for flow cytometry analysis, gentle cell dissociation reagent (Stem Cell 
Technologies) was used to single cell dissociation. Cells were then fixed and permeablized using 
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BD Cytofix/Cytoperm Kit (BD Biosciences) according to manufacturer instructions. Briefly, 
cells were fixed for 15 minutes using BD Cytofix/Cytoperm solution and washed twice in 1x BD 
Perm/Wash Buffer. Cells were incubated on ice with primary antibodies for 1 hour before 
another wash with BD Cytofix/Cytoperm. Finally, cells were suspended in PBS with 2% fetal 
bovine serum (Omega) and data was collected with either an LSRII (BD Biosciences) or an 
LSRFortessa (BD Bioscience). Data analysis was performed with FlowJo software (Treestar).  
 
Immunoblot 
For ARNT/HIF1beta immunoblots, nuclear fractions of cells were obtained using NE-PER 
Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher) according to manufacturer 
instructions. For whole cell lysates cells were harvested in SDS buffer (40mM Tris-HCl pH 6.8, 
3% glycerol, 1% SDS). For all immunoblots protein concentrations were quantified using a BCA 
assay kit (Pierce). IRDye-conjugated secondary antibodies were used and images captured with 
an Odyssey Fc (Licor). 
 
Metabolite Extraction and Analysis 
To extract intracellular metabolites, cells were washed with cold D-PBS followed by a wash with 
cold 150mM ammonium acetate (pH 7.3).  Next, 1ml of -80°C 80% methanol in water (v/v) was 
added to each well of a 12-well plate. Cells were scraped off of the plate and transferred to cold 
1.5 ml Eppendorf tubes. 10 nmol of D/L norvaline was added to cell suspension before 
centrifugation at (1.3 x 1.4 rpm, 4°C).  Supernatant was transferred to a glass vial.  To harvest 
any remaining metabolites, 200μl was added to the cell mixture which was vortexed three times 
for 5 seconds. Centrifugation was repeated and supernatant was transferred into glass vial.  
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Samples were dried was EZ-Elite Personal Evaporator aqueous program for 2 hours and 40 
minutes. Metabolites were resuspended in 70% acetonitrile. For mass spectrometry analysis of a 
sample, 5μl was injected onto a Luna NH2 (150 mm x 2 mm, Phenomenex) column. Samples 
were analyzed with an UltiMate 3000RSLC (Thermo Scientific) coupled to a Q Exactive mass 
spectrometer (Thermo Scientific). The Q Exactive was run with polarity switching (+3.00 
kV / -2.25 kV) in full scan mode with an m/z range of 70-1050. Separation was achieved using 
A) 5 mM NH4AcO (pH 9.9) and B) ACN. The gradient started with 15% A) going to 90% A) 
over 18 min, followed by an isocratic step for 9 min and reversal to the initial 15% A) for 7 min. 
Metabolites and isotopomers were quantified with TraceFinder 3.1 using accurate mass 
measurements (≤ 3 ppm) and retention times. For isotopologue distribution measurements, data 
was corrected for naturally occurring 13C as described previously (Moseley, 2010). Data 
analysis was performed using the formula statistical 14 language R. Fractional contributions 
were calculated using the formula described previously, where mi denotes the intensity of the 
isotopologue, and n marks the number of carbons in the metabolite (Fendt et al., 2013). 
 
Statistical Analysis 
Data were analyzed with Prism (GraphPad). Data were analyzed using two-way ANOVA with 
correction for multiple comparisons. In all cases, p < 0.05 was considered significant. 
 
 
Results 
Low oxygen tension (1% O2) inhibits hPSC neuroectoderm differentiation independent of 
HIF transcriptional activity 
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Low oxygen environments have been shown to both improve reprogramming to pluripotency and 
to promote neuroectoderm differentiation (Mathieu et al., 2014; Xie et al., 2014; Yoshida et al., 
2009). To investigate the role of low oxygen levels in hPSC differentiation, we cultured hPSCs 
in 1% O2 or 21% O2 throughout neuroectoderm differentiation triggered by dual SMAD 
inhibition (Chambers et al., 2009). Differentiation was severely impaired in 1% oxygen 
environment when compared to normoxic conditions (Figure 1A and 1B).  We hypothesized that 
this inhibition could be due to stabilization of HIF1α and HIF2α, which has been shown to 
activate OCT4 expression and improve early reprogramming (Covello et al., 2006; Mathieu et 
al., 2014).  Therefore, we knocked down expression of HIF1β/ARNT, the heterodimeric partner 
for transcriptional activity of both HIF1α and HIF2 α, by stable lentiviral shRNA expression 
(Figure 1C). Hypoxia inhibited differentiation in both the scramble control and ARNT 
knockdown hPSCs suggesting that activation of HIF by hypoxia is not required to inhibit 
differentiation (Figure 1D and 1E). Alternatively, 2-hydroxyglutarate (2HG) produced by lactate 
dehydrogenase and malate dehydrogenase enzymes in hypoxic conditions could play a role in 
inhibiting differentiation (Intlekofer et al., 2015; Oldham et al., 2015). αKG-dependent 
dioxygenases play an important role in hPSC differentiation, and L-2HG is an inhibitor of many 
of the αKG-dependent dioxygenase enzymes (Figueroa et al., 2010; Lu et al., 2012; TeSlaa et al., 
2016).  
 
αKG does not promote differentiation in hypoxic conditions 
Because 2HG competitively inhibits αKG-dependent dioxygenases, we hypothesized that 
addition of αKG may rescue differentiation. To determine whether αKG could rescue the effect 
of low oxygen tension during differentiation, hPSCs were differentiated into neuroectoderm in 
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the presence and absence of dm-αKG in 1% or 21% O2 conditions.  Dm-αKG was unable to 
increase the number of Pax6 positive cells after differentiation under low oxygen tension (Figure 
2A and 2B).  Treatment with dm-αKG under hypoxic conditions has been shown to increase 
2HG levels in cancer cell lines (Intlekofer et al., 2015). This data suggests either that addition of 
αKG causes increased L-2HG accumulation, or that αKG-dependent dioxygenases are directly 
inhibited by low oxygen tension in the context of hPSC differentiation at 1% O2. 
 
HIF is not required for dm-αKG accelerated differentiation 
Dm-αKG can cause the stabilization of HIFs through inhibition of HIF prolyl hydroxylase 2 
(PHD2) despite its metabolism into αKG (Hou et al., 2014). Because dm-αKG can promote 
neuroectoderm differentiation of hPSCs and hypoxia skews differentiation toward ectoderm, we 
hypothesized that HIF could play a role in the effect of dm-αKG on differentiation (TeSlaa et al., 
2016; Xie et al., 2014). Knockdown of HIF1β/ARNT, however, had no effect on dm-αKG 
accelerated differentiation (Figure 2C). Furthermore, low oxygen inhibited differentiation in 
HIF1β/ARNT knockdown hPSCs regardless of dm-αKG supplementation. This data suggests 
that dm-αKG accelerates differentiation independent from its influence on HIF stabilization. 
 
Discussion 
Hypoxia can influence cell fate through multiple mechanisms including stabilization of HIF and 
inhibition of αKG-dependent dioxygenases through direct inhibition or L-2HG accumulation. 
Our data suggests that 1% oxygen inhibits differentiation through inhibition of these 
dioxygenases. Measurement of L-2HG levels should be done to determine if L-2HG is high in 
differentiating hPSCs in 1% O2. Furthermore, differentiation at 2% O2 and 5% O2 should be 
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done with shHIF1β/ARNT hPSCs to determine whether HIF can promote neuroectoderm 
differentiation in more moderate hypoxic conditions and whether L-2HG accumulates in these 
conditions. Interestingly, L-2HG dehydrogenase (L2HGDH), which converts L-2HG back to 
αKG, is expressed at high levels in human iPSCs when compared with fibroblasts, while D-2-
hydroxyglutarate dehydrogenase (D2HGDH), which converts D-2HG to αKG is higher in 
fibroblasts (data not shown). D-2HG, unlike L-2HG, does not increase in hypoxic conditions 
(Intlekofer et al., 2015; Oldham et al., 2015). This suggests that L2HGDH may be important for 
differentiation of tissue exposed to hypoxic conditions during development. Rare autosomal 
recessive mutations in L2HGDH cause only neurological defects including psychomotor 
retardation, cerebellar ataxia, macrocephaly, or epilepsy (Steenweg et al., 2010). This leads to 
the hypothesis that moderate hypoxia promotes neuroectoderm development while L2HGDH 
limits L-2HG accumulation that could inhibit αKG dependent dioxygenases. Furthermore, this 
suggests that early metabolic changes during differentiation may be lineage specific and play a 
role in tissue specification. 
 
Another issue that arises from this work is common practice of maintaining hPSCs in hypoxic 
environments to promote self-renewal (Ludwig et al., 2006a; Ludwig et al., 2006b). An 
outstanding question is whether long term culture in moderate hypoxia can alter L-2HG levels or 
inhibit αKG dependent dioxygenases enough to alter hPSC differentiation or lineage preference. 
Furthermore, culture of hPSCs in feeder free conditions, specifically Essential 8 media (E8), has 
been shown to cause a modest increase 2HG levels (Zhang et al., 2016). It would be interesting 
to see if feeder free conditions cause decreased ability to differentiate through 2HG 
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accumulation. It is unclear, however, which enantiomer of 2HG increases in feeder free 
conditions. 
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Figure Legends 
Figure 1. Severe hypoxia inhibits hPSC differentiation  
(A,B) Flow plot and quantification of the percent PAX6 positive cells in differentiated hPSC 
measured by flow cytometry after 4 days of neuroectoderm differentiation in either normoxic 
(21% O2) or hypoxic conditions (1% O2). 
(C) Immunoblot of ARNT/HIF1β and nuclear loading control HDAC1 in nuclear extracts of H9 
hESCs with lentiviral expression of shRNA targeting ARNT/HIF1β or scramble control. 
(D) Quantification of flow cytometry data of the percent PAX6 positive cells in H9 hESCs 
expressing either shRNA targeting ARNT/HIF1β or scramble control after 4 days of 
differentiation in either normoxic (21% O2) or hypoxic conditions (1% O2). 
*p≤0.05; ***p≤0.001. P values were determined by two-way analysis of variance (ANOVA) 
with correction for multiple comparisons.  
 
Figure 2. αKG cannot rescue severe hypoxia inhibited differentiation and promotes 
differentiation independent of HIF. 
(A,B) Flow plot and quantification of the percent PAX6 positive cells in differentiated HIPS2 
hPSCs measured by flow cytometry after 4 days of neuroectoderm differentiation in either 
normoxic (21% O2) or hypoxic conditions (1% O2) with addition of dm-αKG where indicated. 
(C) Flow plot and quantification of the percent PAX6 positive cells in differentiated H9 hPSCs 
expressing either shRNA targeting ARNT/HIF1β or scramble control measured by flow 
cytometry after 4 days of neuroectoderm differentiation in either normoxic (21% O2) or hypoxic 
conditions (1% O2) with addition of dm-αKG where indicated. 
 84 
*p≤0.05. P values were determined by two-way analysis of variance (ANOVA) with correction 
for multiple comparisons. 
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Chapter 5: 
 
Conclusion 
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Pluripotent stem cells can be cultured in two distinct developmental states: the naïve pluripotent state 
which corresponds to the inner cell mass of the preimplantation blastocyst and the primed pluripotent 
state which corresponds to the epiblast post uterine implantation (Nichols and Smith, 2009). These 
different developmental stages are characterized by differences in their response to signaling pathways, 
their epigenetic landscape and their metabolism (Greber et al., 2010; Hayashi et al., 2008; Leitch et al., 
2013; Marks et al., 2012; Zhou et al., 2012). While mouse pluripotent cells can be derived from either the 
pre- or post-implantation embryo to generate naïve or primed pluripotent stem cells, respectively, human 
pluripotent stem cells (hPSCs) have traditionally been cultured in primed pluripotent conditions despite 
being derived from the preimplantation epiblast (Nichols and Smith, 2009).  
 
α-Ketoglutarate (αKG) can promote self-renewal of the naïve pluripotent state by promoting the activity 
of αKG-dependent enzymes that maintain low DNA and histone methylation levels characteristic of the 
naïve state (Carey et al., 2014). hPSCs, which are maintained in the primed pluripotent state, however, 
have relatively higher levels of both DNA and histone methylation (Liao et al., 2015). Therefore, we 
hypothesized that αKG may play a different role in hPSCs. Furthermore, inhibition of αKG-dependent 
dioxygenases is often seen to block differentiation in cancer, and activity of several JHDMs and TET 
enzymes are required for differentiation of PSCs (Dawlaty et al., 2014; Lu et al., 2012). Despite these 
connections, the role of αKG in primed hPSC differentiation has not been previously investigated. 
 
To determine the role of αKG in hPSCs, we first investigated how TCA cycle metabolites including αKG 
are produced in hPSCs in comparison to hPSC-derived differentiated cells. To do this we fed hPSCs and 
differentiatied cells 13C-labeled glucose, glutamine and glutamate and measured intracellular metabolites 
using ultra high pressure liquid chromatography combined with mass spectrometry (UHPLC-MS).  Our 
results showed that hPSCs have active TCA cycles with carbons from glucose and glutamine robustly 
contributing to TCA cycle metabolite production. Furthermore, despite low respiration in hPSCs 
compared to differentiated cells, more carbon from glucose and glutamine was seen in TCA cycle 
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metabolites in hPSCs. This suggested that other carbon sources may contributie to respiration upon 
differentiation. We then measured glutamate uptake and incorporation and saw that upon differentiation, 
cells became metabolically flexible gaining the ability to use glutamate in their TCA cycle. Metabolic 
flexibility is important for normal cellular function and the response to metabolic stress. Limitations in 
cellular and organismal metabolic flexibility is often seen in disease states such as cancer or diabetes 
(Goodpaster and Sparks; Olson et al., 2016). It seems that hPSCs are metabolically less flexible when 
compared to differentiated cells. This idea is supported by other work showing that hPSCs are dependent 
on glutamine for their survival (Tohyama et al., 2016). This could be one additional way in which disease 
states such as cancer resemble a stem cell like or less differentiated state. 
 
Next, we more specifically investigated αKG production which can be made either by glutamate 
dehydrogenase or transaminase enzymes. In proliferative cells transaminase enzymes are often active to 
conserve nitrogen by producing amino acids rather than releasing the nitrogen as ammonia (Coloff et al., 
2016). To measure transaminase activity, we used 15N2-glutamine to measure amine group transfer from 
glutamate to amino acids. We found robust activity of many transaminases including the glutamate 
pyruvate transaminases and glutamate oxaloacetate transaminases suggesting that αKG is robustly 
produced by these enzymes in hPSCs. High activity of transaminase enzymes serves to help support the 
biosynthetic demands of proliferative cells by producing amino acids important for both nucleotide 
biosynthesis, such as aspartate, and protein translation. In addition, these enzymes also produce αKG 
which can alter gene expression through αKG-dependent dioxygenases. Therefore, these enzymes may 
serve as a link between proliferation and epigenetic regulation coordinating biosynthesis and gene 
expression. 
 
Because hPSCs robustly produce αKG, we hypothesized that it may be important for αKG-dependent 
enzyme function during differentiation. To determine whether αKG can affect differentiation, ectoderm 
and endoderm differentiations were performed with supplementation of αKG or cell permeable dimethyl-
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αKG (dm-αKG) in the media. Both dm-αKG and αKG supplementation increased the percent of cells 
positive for lineage specific markers early in differentiation. From this data, we concluded that αKG 
accelerates the differentiation of primed hPSCs. This differentiation-promoting role of αKG is distinct 
from its role in supporting self-renewal of naïve mESCs (Carey et al., 2014). Based on our results we 
hypothesized that this difference is due differences in the pluripotent states that primed hPSCs and naïve 
mESCs exist in rather than species-dependent differences. To test this hypothesis, we obtained mouse 
primed pluripotent cells, called epiblast stem cells (EpiSCs), and differentiated them in the presence of 
dm-αKG. Dm-αKG accelerated the differentiation of mouse EpiSCs suggesting that αKG plays a different 
role in different pluripotent states. To further confirm the role of αKG in primed hPSCs, we next tried to 
decrease the activity of the αKG-dependent dioxygenases either by decreasing αKG levels or by 
increasing levels of succinate, a competitive inhibitor of the dioxygenase enzymes. Two different 
transaminase inhibitors were used to decrease αKG levels, aminooxyacetate and L-cycloserine, and a 
succinate dehydrogenase inhibitor, 3-nitropropionic acid. All three inhibitors caused a significant delay or 
inhibition of neuroectoderm differentiation. This data was consistent with our conclusion that αKG 
promotes primed hPSC differentiation.  
 
Finally, we looked at the epigenetic targets of αKG-dependent dioxygenases, the methylation of histone 
tails and cytosine methylation of the DNA. During primed hPSC differentiation, dm-αKG causes a 
decrease in histone trimethyl marks and an increase in the ratio of 5-hydroxymethylcytosin to 5-
methylcytosine. Combined these data suggest a differentiation promoting role for αKG in primed hPSCs 
probably through its action on epigenetic members of the αKG-dependent dioxygenase family. These 
results highlight the metabolic, epigenetic, and functional differences that exist between the naïve and 
primed pluripotent states. Primed pluripotent cells are prepared for differentiation while naïve pluripotent 
cells seem to be in a more stable self-renewing state. This is consistent with epigenetic studies that have 
shown that ablation of epigenetic repressors reinforces the self-renewal of naïve PSCs, while ablation of 
the same epigenetic repressors in the primed PSCs promotes differentiation (Weinberger et al., 2016). 
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To follow up the study of αKG in hPSC differentiation, I briefly investigated the role of hypoxia 
inducible factors (HIFs) and oxygen tension in early differentiation. One motivation for this work was to 
determine whether dm-αKG acts through stabilization of HIFs by inhibiting prolyl-4-hydroxylase 2 
(PHD2) (Hou et al., 2014). To investigate this question, HIF1β/ARNT was knocked down in hPSCs. 
Depletion of HIF1β/ARNT does not negate the effect of dm-αKG suggesting that HIFs do not have a 
driving role in dm-αKG driven differentiation. This is consistent with our results in which αKG, which 
activates PHD2, promoted primed hPSC differentiation. 
 
Interestingly, while studying the role of HIF in αKG-promoted differentiation, I found that low oxygen 
(1% O2) environments inhibit differentiation of hPSCs into neuroectoderm. Furthermore, I found that this 
inhibition occurs through a HIF independent pathway. αKG-dependent dioxygenases, which are important 
in early differentiation, require oxygen for their activity and can be inhibited by 2-hydroxyglutarate (2-
HG) (Loenarz and Schofield, 2011; Xu et al., 2011). L-2-hydroxyglutarate levels increase in hypoxic 
environments and therefore this could be a mechanism by which differentiation is inhibited by very low 
oxygen tensions in hPSCs (Intlekofer et al., 2015; Oldham et al., 2015). More work needs to be done to 
understand how varying low oxygen tensions can promote self-renewal and inhibit differentiation in some 
contexts and promote ectoderm differentiation in others (Ezashi et al., 2005; Xie et al., 2014). These 
differences may be due to differences in the levels of oxygen. In this model, severe hypoxia may inhibit 
differentiation while moderate hypoxia may promote differentiation into neuroectoderm. 
 
Combined with other current results in the field, my work demonstrates the context-specific role that 
metabolites can have in regulating cellular fate. Furthermore, it suggests that each component of 
differentiation medium as well as other environmental factors can influence the efficiency, completeness, 
and speed of cellular maturation. Therefore, one goal of studying hPSC metabolism could be to 
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manipulate metabolism to improve differentiation of hPSCs. To achieve this purpose, however, 
systematic studies will need to be performed in which metabolic perturbations are made during periods of 
differentiation of hPSCs into multiple lineages. A deeper understanding of the metabolic requirements of 
each germ layer particularly during early differentiation has the potential to inform differentiation 
protocols. 
 
While studies focused on single metabolites or pathways are informative, a broader approach would 
accelerate progress in the field. Therefore, another strategy to improve the production of mature and 
functional differentiated cells would be to carefully design differentiation media and the extracellular 
matrix throughout the differentiation to simulate the environment that a cell is exposed to during normal 
development. However, increased understanding of human development in vivo is required for this 
strategy. Because studies of human development of this nature are not feasible, studies in hPSCs will 
probably need to be guided by developmental biology in model organisms. 
 
A more practical application of this idea could be to design a better in vitro environment for the culture of 
naïve hPSCs. While naïve culture conditions for hPSCs have been established, many questions still exist 
regarding the physiologic relevance and usefulness of naïve hPSCs maintained in these conditions. 
Designing novel culture conditions that better model the environment that the ICM is exposed to in vivo 
could improve the culture of naïve hPSCs and reduce the need for the numerous small molecule inhibitors 
currently used for this purpose. The ICM of the blastocyst is exposed to both trophectoderm cells and the 
blastocoel fluid that exists in the cavity of the embryo. The volume of the blastocoel fluid is minimal 
which may present limitations for metabolomic studies. Some metabolic characterization of the blastocoel 
fluid has been done in bovine blastocysts, however. Interestingly lactate, aspartate, and glycine are all 
very high in bovine blastocoel fluid and are taken up by the inner cell mass (Gopichandran and Leese, 
2003). It would be interesting to see how these metabolites change hPSC metabolism, self-renewal and 
differentiation. A pitfall to this approach is that the ICM does not self-renew in vivo, but continues to 
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differentiate. Therefore, modeling of the in vivo environment of the ICM may not improve self-renewal of 
the human naïve PSCs. Feeder layers can impact cellular metabolism and the differentiation potential of 
hPSCs (Gu et al., 2016; Lee et al., 2015; Ojala et al., 2012; Zhang et al., 2016). In vivo the trophectoderm 
secretes metabolites and other factors into the blastocoel fluid providing the environment for the ICM. 
Therefore, study of the metabolism of the human trophectoderm could lead to a deeper understanding of 
how naïve and primed pluripotency can be supported. In the bovine system, the trophectoderm secretes 
more lactate than the ICM (Gopichandran and Leese, 2003).  
 
Another approach to investigating the metabolism of the naïve pluripotent state is to reprogram primed 
pluripotent stem cells to naïve pluripotent cells while altering the metabolism through addition of 
metabolites, small molecule inhibitors, or other metabolic supplements. Because of its role in supporting 
the self-renewal of naïve PSCs (Carey et al., 2014), αKG is a candidate metabolite that could improve 
reprograming to the naïve pluripotent state. Oxidative phosphorylation (OXPHOS) promotes conversion 
of mouse EpiSCs into naïve PSCs (Sone et al., 2017), however it remains to be seen if OXPHOS will also 
promote the naïve state in human PSCs. It may be interesting to add metabolites that are enriched in the 
blastocoel fluid during the reprogramming process to determine if they improve conversion to the naïve 
state.  
 
Beyond using metabolism to improve methods for culturing and differentiating hPSCs, much work can be 
done to better understand the mechanisms that regulate mitochondrial metabolism, morphology, 
homeostasis, and apoptosis in primed hPSCs. Primed hPSCs exhibit low levels of OXPHOS and respire at 
their maximum capacity despite having numerous mitochondria and fairly active TCA cycles (Zhang et 
al., 2011). While high levels of uncoupling protein 2 (UCP2) and pyruvate dehydrogenase kinase (PDK) 
promote the shunting of TCA cycle metabolites away from OXPHOS, there are probably other 
mechanisms limiting OXPHOS activity in hPSCs. Furthermore, mitochondria in hPSCs have an immature 
morphology exhibited by perinuclear and punctate structure with swollen cristae (Suhr et al., 2010; Zhang 
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et al., 2011). However, despite many descriptive studies, very little work has been done to identify 
mechanistic regulators of mitochondrial morphology and function in hPSCs. Interestingly, hPSCs are 
more sensitive to mitochondria mediated apoptosis in response to many cellular stresses when compared 
to differentiated cell types (TeSlaa et al., 2016). Rapid degradation of p53 and activated Bax sequestered 
to the golgi apparatus in hPSCs are partially responsible for their sensitivity to apoptotic stimuli (Dumitru 
et al.; Liu et al., 2013; Setoguchi et al., 2016). Mechanisms related to the differences in mitochondrial 
morphology and turnover, however, remain to be identified. 
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